Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Notes underwriting agrmnt
Inv. presentation
Quarterly results
Acq. announced
|
|
Vistagen Therapeutics, Inc. (VTGN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/06/2023 |
4
| COMMODORE CAPITAL LP (10% Owner) has filed a Form 4 on Vistagen Therapeutics, Inc.|
Txns:
| Granted 2,788,620 options to buy
@ $0.001, valued at
$2.8k
Granted 1,394,310 options to buy
@ $5.38, valued at
$7.5M
Granted 1,690,014 options to buy
@ $8.877, valued at
$15M
|
|
| 08/23/2023 |
4
| Anderson Cynthia Lynn (CFO) has filed a Form 4 on Vistagen Therapeutics, Inc.|
Txns:
| Granted 8,333 options to buy
@ $5.34, valued at
$44.5k
|
|
| 08/09/2023 |
4
| COMMODORE CAPITAL LP (10% Owner) has filed a Form 4 on Vistagen Therapeutics, Inc.|
Txns:
| Bought 775,756 shares
@ $23.153, valued at
$18M
|
|
| 07/05/2023 |
4
| Singh Shawn (CEO) has filed a Form 4 on Vistagen Therapeutics, Inc.|
Txns:
| Granted 167 shares
@ $1.5895, valued at
$265.4 |
|
| 07/05/2023 |
4
| Adler Reid G. (CHIEF LEGAL OFFICER) has filed a Form 4 on Vistagen Therapeutics, Inc.|
Txns:
| Granted 167 shares
@ $1.5895, valued at
$265.4 |
|
| 07/05/2023 |
4
| DOTSON JERROLD DUANE (VP, CFO) has filed a Form 4 on Vistagen Therapeutics, Inc.|
Txns:
| Granted 167 shares
@ $1.5895, valued at
$265.4 |
|
| 01/03/2023 |
4
| DOTSON JERROLD DUANE (VP, CFO AND SECRETARY) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 5,000 shares
@ $0.0876, valued at
$438 |
|
| 01/03/2023 |
4
| Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 5,000 shares
@ $0.0876, valued at
$438 |
|
| 08/22/2022 |
4
| GIN JERRY B (Director) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Bought 100,000 shares
@ $0.1787, valued at
$17.9k
Bought 100,000 shares
@ $0.1787, valued at
$17.9k
|
|
| 08/19/2022 |
4
| Adler Reid G. (CHIEF LEGAL OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Bought 300,000 shares
@ $0.1697, valued at
$50.9k
|
|
| 08/18/2022 |
4
| Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Bought 600,000 shares
@ $0.172, valued at
$103.2k
|
|
| 07/15/2022 |
4
| DOTSON JERROLD DUANE (VP, CFO AND SECRETARY) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 5,000 shares
@ $0.748, valued at
$3.7k
|
|
| 07/15/2022 |
4
| Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 5,000 shares
@ $0.748, valued at
$3.7k
|
|
| 07/15/2022 |
4
| Smith Mark Alan (CHIEF MEDICAL OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 5,000 shares
@ $0.748, valued at
$3.7k
|
|
| 07/14/2022 |
4
| Venrock Healthcare Capital Partners II, L.P. (10% Owner) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Sold 60,000 shares
@ $0.89, valued at
$53.4k
|
|
| 05/16/2022 |
4
| Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Exercised 100,000 options to buy
@ $1, valued at
$100k
|
|
| 05/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2022 |
4
| DOTSON JERROLD DUANE (VP, CFO AND SECRETARY) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 150,000 options to buy
@ $1.37, valued at
$205.5k
|
|
| 03/03/2022 |
4
| Smith Mark Alan (CHIEF MEDICAL OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 150,000 options to buy
@ $1.37, valued at
$205.5k
|
|
| 03/03/2022 |
4
| Cunningham Ann Michelle (CHIEF COMMERCIAL OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 150,000 options to buy
@ $1.37, valued at
$205.5k
|
|
| 03/03/2022 |
4
| Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 300,000 options to buy
@ $1.37, valued at
$411k
|
|
| 03/03/2022 |
4
| GIN JERRY B (Director) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $1.37, valued at
$137k
|
|
| 03/03/2022 |
4
| FitzPatrick Margaret M (Director) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $1.37, valued at
$137k
|
|
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2022 |
4
| Rotunno Mary L. (Director) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $1.37, valued at
$137k
|
|
| 03/03/2022 |
4
| Curley Joanne (Director) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $1.37, valued at
$137k
|
|
| 01/12/2022 |
4
| DOTSON JERROLD DUANE (VP, CFO AND SECRETARY) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Exercised 18,750 options to buy
@ $1, valued at
$18.8k
|
|
| 01/03/2022 |
4
| Smith Mark Alan (CHIEF MEDICAL OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 2,655 shares
@ $1.6575, valued at
$4.4k
|
|
| 01/03/2022 |
4
| DOTSON JERROLD DUANE (VP, CFO AND SECRETARY) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 3,575 shares
@ $1.6575, valued at
$5.9k
|
|
| 01/03/2022 |
4
| SNODGRASS H. RALPH (PRES./CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 3,623 shares
@ $1.6575, valued at
$6k
|
|
| 01/03/2022 |
4
| Singh Shawn (CEO) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Granted 3,623 shares
@ $1.6575, valued at
$6k
|
|
| 09/08/2021 |
4
| DOTSON JERROLD DUANE (VP, CFO AND SECRETARY) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Sold 30,000 shares
@ $3.125, valued at
$93.8k
|
|
| 09/03/2021 |
4
| SNODGRASS H. RALPH (PRES./CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Gifted 740 shares
@ $0
Gifted 1,111 shares
@ $0 |
|
| 08/18/2021 |
4
| SNODGRASS H. RALPH (PRES./CHIEF SCIENTIFIC OFFICER) has filed a Form 4 on VistaGen Therapeutics, Inc.|
Txns:
| Bought 3,750 shares
@ $2.73, valued at
$10.2k
|
|
|
|
|